Erratum: Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum].

IF 2.7 3区医学 Q2 RESPIRATORY SYSTEM

International Journal of Chronic Obstructive Pulmonary Disease Pub Date : 2024-08-06 eCollection Date: 2024-01-01 DOI:10.2147/COPD.S484253

引用次数: 0

Abstract

[This corrects the article DOI: 10.2147/COPD.S432963.].

查看原文本刊更多论文

勘误：慢性阻塞性肺病患者接受布地奈德/甘珀酸/富马酸奥莫特罗单吸入剂三联疗法后的病情加重和实际疗效：EROS（美国）研究的结果[更正]。

[此处更正了文章 DOI：10.2147/COPD.S432963]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Chronic Obstructive Pulmonary Disease RESPIRATORY SYSTEM-

CiteScore

4.80

自引率

10.70%

发文量

372

审稿时长

16 weeks

期刊介绍： An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals